Here's a betrayal you didn't see coming: your nervous system, which is supposed to be on your team, might be helping tumors evade your immune system. Not cool, nervous system. A comprehensive review in the Journal of Hematology and Oncology lays out the growing evidence that nerves actively help cancers dodge the immune cells trying to kill them.
If you thought the relationship between cancer and the immune system was complicated, wait until you add the nervous system to the mix.
The Three-Way Relationship Nobody Asked For
The past decade has transformed how we think about cancer treatment. Immunotherapy, which teaches your own immune cells to recognize and attack tumors, has produced genuine cures in some patients. It's one of the biggest success stories in modern oncology.
But tumors are crafty. They've evolved multiple ways to hide from immune surveillance, suppress immune responses, and generally make themselves invisible to the cells that should be destroying them. And according to this review, one of their sneakiest tricks involves recruiting the nervous system as an accomplice.
That's right: your nerves might be collaborating with the enemy.
How Nerves Help Tumors Play Hide and Seek
The emerging field of cancer neuroscience has revealed that tumors don't passively sit in tissues minding their own business. They actively recruit nerves into their microenvironment, and those nerves then do the tumor's bidding.
Neurotransmitters and neuropeptides, the chemical messengers neurons use to communicate, can directly affect immune cell behavior. And it turns out tumors can manipulate this signaling to suppress immune responses.
B cells, T cells, macrophages, dendritic cells, myeloid-derived suppressor cells: tumors can dial down all of them through neural signals. The nerves release chemicals that tell immune cells to calm down, look the other way, don't attack the tumor. The net effect is often profound immune suppression, allowing tumors to grow unchecked while your immune system stands around wondering why it's so tired.
Stress Literally Makes It Worse
Here's a finding that will make you want to take up meditation: stress hormones appear to help tumors.
The review highlights beta-adrenergic receptors, which respond to stress hormones like adrenaline, as having particular therapeutic potential. When you're stressed, your body releases adrenaline. Tumors, it turns out, can use this signal to suppress immune activity.
Beta-blockers, commonly prescribed for high blood pressure and anxiety, have shown intriguing anti-cancer effects in some studies. The mechanism might be that they block the stress-hormone signals that tumors exploit for survival.
So you're stressed about having cancer, and that stress is literally helping the cancer grow. Biology can be cruel.
Old Drugs, New Applications
One genuinely exciting aspect of this research is the potential to repurpose existing medications. Drugs targeting neural signaling pathways already exist and have decades of safety data. If they enhance cancer immunotherapy, they could move into clinical use relatively quickly.
No need to wait years for new drugs to be developed and tested when the pharmacy already has something that might work. Beta-blockers, cholinergic modulators, and other neuroactive drugs are already available. The question is just whether they can complement existing cancer treatments.
Cancer Treatment Needs to Think Bigger
This review underscores something that's becoming increasingly clear: cancer isn't just a disease of rogue cells. It's a systems-level problem involving metabolism, blood vessels, the immune system, and now clearly the nervous system.
Treatment strategies that focus only on killing cancer cells are missing the broader ecosystem. The most effective approaches might need to target the tumor AND its neural allies AND restore immune function all at once.
Your body works as one system. Treating cancer might need to respect that interconnectedness rather than pretending tumors exist in isolation.
The nervous system was supposed to be the good guy. Turns out it's been playing both sides. Time to bring it back to Team Human.
Reference: Zhang C, et al. (2025). The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities. Journal of Hematology and Oncology. doi: 10.1186/s13045-025-01748-5 | PMID: 41152924
Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.